Tre af undersøgelserne var åbne, hvilket vil sige, at lægemidlet ikke blev sammenlignet med nogen anden behandling, og at patienterne godt vidste, de fik Hycamtin.
Three studies were ‘ open ’, meaning that the medicine was not compared to any other treatment and the patients knew that they were receiving Hycamtin.